The
Office of Surveillance analyzes the economics of infectious
diseases, assessing both the economic burden of disease as
well as the costs and benefits of interventions. A wide range
of methodologies are used, including the construction of mathematical
models, the statistical analysis of existing datasets, and
implementation of original experiments and surveys. Outcomes
used to assess both the burden of disease and the value of
intervention include dollars, Disability-Adjusted Life Years
(DALYs), and Quality-Adjusted Life Years (QALYs).
The
Office of Surveillance works with all the divisions and branches
within the National Center for Infectious Diseases. Analyses
have been conducted, or are in progress, on a wide range of
diseases and issues, including raccoon rabies, Lyme disease,
pandemic influenza, dengue, pertussis, hepatitis A, hepatitis
B, E. coli O157:H7 infection, toxoplasmosis, meningitis,
the value of reduced use of antibiotics to reduce antimicrobial
resistance, malaria, control of hospital-acquired infections,
and the economics of planning and preparing for possible bioterrorist
attacks.
|